bioMerieux (Paris:BIM), a world leader in the field of in vitro diagnostics, provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety. The Company's products are used for diagnosing infectious diseases and providing high medical value results for cancer screening and monitoring and cardiovascular emergencies.

bioMerieux (Paris:BIM), a world leader in the field of in vitro diagnostics, provides diagnostic solutions (reagents, instruments, software) which determine the source of disease and contamination to improve patient health and ensure consumer safety....Show all

See All Exits Recent Exits